The Lancet infectious diseases
The most recent articles from:
Lancet Infect Dis
-
Biography Historical Article
BT Slingsby: driving forward innovation in global health.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial.
Ceftriaxone with or without a macrolide antibiotic is a recommended treatment for patients with community-acquired pneumonia requiring hospital admission and intravenous antibiotic treatment. We aimed to assess the efficacy and safety of ceftaroline fosamil compared with ceftriaxone in the treatment of Asian patients admitted to hospital with community-acquired pneumonia. ⋯ AstraZeneca.